Clinical Trial Trends 2026: Transforming Drug Development
Clinical Trial Trends 2026: Transforming Drug DevelopmentThe global clinical trial ecosystem is under pressure from every direction. Drug development costs continue to climb an average Phase III program now runs well above $280 million in the United States alone. Patient recruitment accounts for as much as 30% of total trial timelines, yet dropout rates remain stubbornly high. Regulatory submissions are more complex than they were a decade ago, partly because trials themselves generate three times more data than they [...]
